Milestone Scientific starts commercial sales of CompuFlo Epidural System.

• Milestone Scientific initiates commercial sales of CompuFlo Epidural System • System provides painless and precise injections • The Painless Center in Tenafly, NJ, starts sales • Led by Chi-Shin Jason Chiu, MD, a pain management expert • CompuFlo Epidural System improves patient outcomes • Milestone Scientific's first commercial sale of the CompuFlo System

Milestone Scientific (MLSS), a leading developer of computer-controlled anesthetic systems, has initiated commercial sales of its CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey. This significant milestone marks the company's first commercial sale of the innovative epidural system, which leverages proprietary Dynamic Pressure Sensing Technology® to enhance patient comfort and safety during procedures.

The Painless Center, led by Dr. Chi-Shin Jason Chiu, a double board-certified physician in Pain Management and Anesthesiology, is set to integrate the CompuFlo® system into its clinical practice. The system provides real-time feedback for accurate epidural space identification, significantly reducing complications such as false loss of resistance and dural puncture. This technology is designed to improve procedural efficiency and patient outcomes, aligning with Milestone Scientific's mission to advance precision anesthetic delivery worldwide.

The commercial rollout of the CompuFlo® Epidural System at The Painless Center is part of Milestone Scientific's broader strategy to expand the adoption of its innovative technology across U.S. and international markets. The company has been actively pursuing partnerships with medical institutions and securing favorable Medicare Part B payment rates to facilitate broader accessibility of its products.

Milestone Scientific's latest financial performance highlights the company's commitment to growth and innovation. In the first quarter of 2025, the company reported revenue of $2.2 million, with the medical segment demonstrating increased adoption of the CompuFlo® Epidural System [2]. The company's strategic appointments, such as the recent addition of Shanth Thiyagalingam to its Board of Directors, further underscore its dedication to expanding market penetration and product innovation [3].

As Milestone Scientific continues to drive the adoption of its CompuFlo® Epidural System, investors and healthcare professionals can expect to see further advancements in pain management technology, contributing to improved patient care and procedural efficiency.

References:
[1] https://www.stocktitan.net/news/MLSS/
[2] https://www.stocktitan.net/news/MLSS/